STOCK-BASED COMPENSATION

We currently have stock-based compensation plans in place for our directors, officers, employees, consultants and advisors. Under the terms of these plans we may grant restricted shares and stock options for the purchase of our common stock. The stock-based compensation is granted under terms determined by our Compensation Committee. Our standard stock option grants have a maximum term of 10 years, generally vest over periods ranging between one and five years, and are granted with an exercise price equal to the fair market value of the common stock on the date of grant. Restricted stock is valued at the market value of the common stock on the date of grant and generally vests over periods of three to five years. All dividends paid on restricted stock, whether vested or unvested, are paid to the shareholder.

Information regarding our stock option plans for the three months ended March 31, 2019 is as follows:



	Number of Shares	Weighted Average Exercise Price per Share		Weighted Average Contractual Term	Aggregate Intrinsic Value
Options outstanding, beginning of year	69,123	$	11.10
Options outstanding, end of quarter	69,123	$	11.10	6.1	$	734,164
Options exercisable, end of quarter	50,053	$	10.92	6.1	$	540,695
Option price range at end of quarter	$9.97 to $12.83
Option price of exercisable shares	$9.97 to $12.83

໿

During each of the three months ended March 31, 2019 and 2018, we expensed $12 thousand in stock-based compensation under stock option awards.

There were no options granted during the three months ended March 31, 2019 and 2018. Expected future expense relating to the unvested options outstanding as of March 31, 2019 is $54 thousand over a weighted average period of 1.1 years. Upon exercise of vested options, management expects to draw on common stock as the source of the shares.

The summary of changes in unvested restricted stock awards for the three months ended March 31, 2019, is as follows:



	Number of Shares		Weighted Average Grant Date Fair Value
Unvested restricted stock, beginning of year	97,465		$	24.45
Granted	41,832		22.29
Forfeited	(15,954	)	24.36
Vested	(28,178	)	20.58
Unvested restricted stock, end of period	95,165		$	24.65

During the three months ended March 31, 2019 and 2018, we expensed $178 thousand and $153 thousand, respectively, in stock-based compensation under restricted stock awards.

At March 31, 2019, unrecognized compensation expense for unvested restricted stock was $2 million, which is expected to be recognized over an average period of 2.4 years.